Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Grasshopper say not that I have found the truth but rather I have found a truth.
Vino did happen to read anything about a possible FDA issue anywhere.
KS, I know you don't believe me but I am long ISCR and I do trade shares whenever possible to mitigate my risk. It's just that I am not a Kool-Aid drinking type of investor. I find it helpful to understand both the positives and the negatives. I may post more of what you consider negative, but that's because all of these boards are full of people who are what I describe as pumptards. I believe if GenStrips can be successfuly launched and they can get anywhere near the revenue and gross margin(although still a little light) projections that this could be a nice investment. I also know from experience that these things are fraught with risks, so only time will tell. Have a Great Day!
Did you read the guidance reports. As Ks would say call the company if you have questions. But you should pass that bong as this has become hilarious.
Vino are you suggesting that Genstrip sales started in October? If so then please pass the bong.
Ks thank you for the kind reply. I have all the information that I need at this point. Once you understand what guidance is you will find your answer grasshopper.
Vino, what do expect from the quarterly report that would move the PPS.
Pro-Trader, I will ask again. What was the purpose of posting a PR from 1 year ago for something that never happened? Are you trying to highlight something the company did not accomplish? This doesn't make sense as you seem to really like this company.
Thanks,
The PR was from Feb 2010. 1 year ago.
No, I was looking to some kind of link to actually view the Infomercial not the PR. In the PR it stated that it would be on youtube, myspace, etc. The funny thing is that you would post this PR at all! I am curiuos as to what was the purpose of posting this ?
The truth is that our moderator posted about the infocommercial. Simple as that, please take up your issue with the moderator.
Protrader, was the infocommercial ever produced and could you provide us with a link. I searched YouTube for instacare and could only fiound a video about an ingrown toe nail.
You will be fine if the company can ever execute on their plans, but therein lies the problem. The company never seems to be able to do what it plans to do. Don’t take my word for it, go back and look to see what they said they were going to do and compare it to what actually happened. All IMHO
InstaCare Deleted From OTCBB
01/27/2011
InstaCare Corp.s common stock has been deleted from OTC Bulletin Board (OTCBB) effective January 27, 2011 on account of its failure to comply with Rule 15c2-11.
My understanding is that Janis quit! The other part of the AMEX strategy was to file a Provisional Patent Application and have it appraised. I don't think that is possible given that patent's are not issued based upon a Provisional Patent Application. Does anyone know if a regular utility patent was ever filed?? IMHO
Payne, I agree it is not very encouraging. The PPS has not moved much since Walling's report was released. In my humble opinion I believe that serious money is not buying into this either. In my opinion this will move only if ISCR is able to produce results. I am long ISCR with reservations based upon past promises verses actual results. Good Luck.
Payne, the relationship with Walling goes way back to at least the Caredecision days.
I'll let you come to your own conclusions on the accuracy of previous independent(wink, wink)guidance endorsements.
http://www.highbeam.com/doc/1G1-131555630.html
IMHO
Did Mr. Sensitivity Leave Mad or just leave?
Dear Mr. Sensitivity,
My understanding is that ISCR filed a Provisional Patent Application. Now, tell me how a patent would be issued based upon a Provisional Patent Application. I am open to the ideas of others and thought that maybe ISCR had filed a regular utility patent that I did not know about! Do you know if they have filed for the patent? Thanks for your kind reply!
Congress gives inventors a third approach: File a provisional patent application (PPA) on the invention. Filing a PPA allows an inventor to claim "patent pending" status for the invention for 12 months, but involves only a small fraction of the work and cost of a regular patent application. All that is required to file a PPA is an $80 fee ($160 for large companies) and:
a detailed description of the invention telling how to make and use it (the legal standards for the description are the same as those for a regular patent application),
informal drawing(s), if they are needed to understand how to make and use the invention, and
a one-page cover sheet.
If you have written a technical paper for a journal, you can submit it as the description of the invention, as long as it meets the legal standards for describing how to make and use the invention.
Because the PPA is considered a legal substitute for building and testing the invention (which is called "actually reducing the invention to practice") and is not intended to be a regular patent application, you don't need to include:
an abstract or summary
patent claims
a Patent Application Declaration (a statement under penalty of perjury that you are the true inventor and have disclosed all information you know that would be relevant to the examination of the application), or
an Information Disclosure Statement (disclosure of all relevant prior art known to you).
After You File a PPA
If you file a PPA so that you can claim patent pending status, but then decide not to follow up with a regular patent application, your PPA will be thrown away after one year. You can still file a regular patent application later, but you won't be able to get any benefit from the earlier PPA filing date.
If you file a regular patent application within one year of filing the PPA, you can claim the PPA's filing date and can rely on its date if necessary. Two reasons you may wish to claim the earlier filing date on your invention are:
You want to rely on the PPA filing date to prove that your invention came before other similar developments (called "prior art") that would block your claim to invention.
A competing patent application claiming the same invention was filed after your PPA but before your regular patent application and the U.S. Patent and Trademark Office (USPTO) has declared an "interference."
Your regular patent application may include any new matter (technical information about the invention) that wasn't in the PPA, but you won't be able to rely on the PPA's filing date for any such new matter.
Value, I was not aware that ISCR had actually filed for the patent. Do you know when this was filed?
I know that ISCR has some of the best consultants in the industry, but here's a few helpful tips for them anyway:
Improving your targeted marketing can only be achieved if you record, measure and monitor your targeted marketing strategies.
Marketing is not a precise science, so the results of any actions cannot be predicted. Targeted marketing will require some experimenting to find just the right approach that works for your business. And if you are experimenting, it's important that you keep records of what you do and what the results were.
Also, it can help to motivate you (or whoever you have delegated the work to) if you know what sort of success rate to expect. If you hit a 2 per cent conversion rate this week, you might feel disappointed - unless you realize that in the previous two weeks it was only 1 per cent.
If you are using a database or some sort of contact management software, then this recording can be seamlessly integrated into your targeted marketing process. Ideally, you should be recording and retaining the following for each batch of letters you send out:
• The source of the names and addresses
• The date(s) when they were researched
• The actual letter sent
• How many follow-up calls in total you made
• How many of these resulted in a contact with the person you were aiming to reach (a 4:1 calls: contact ratio is not unusual)
• How many of these contacts got the results you wanted (e.g. a sales meeting)
• Subsequently, how many sales (and the value of the sales) resulted from this particular mail shot.
This may sound tedious, but it is essential if you are to change your targeted marketing approach as a result of being more or less successful with a particular:
• Market sector
• Source of mailing names
• Wording of a sales letter
If you only change one variable at a time and you record and measure the results, you will have a very powerful marketing weapon at your disposal.
Good luck!
ALL IMHO
Albert Einstein once said "The definition of insanity is doing the same thing over and over again and expecting different results".
ALL IMHO
12/31/2005
Since inception, we have and will continue to focus our marketing efforts towards general medical and pharmaceutical medical applications through our E-Health handheld information appliance (PDA) software application package, and a permanently affixed handheld information appliance and Wi-Fi (wireless) network. Specifically we have marketed our line of MD@Hand PDA-based medical communication network products to the medical insurance and pharmacy benefits management segments of the healthcare markets.
We have implemented a targeted marketing campaign to educate healthcare providers about our medical technology solutions; targeting the physician providers who specialize in care for the indigent through the provision of technology, products and services that specifically respond to the needs and requirements of that market. We market our suite of medical software products by emphasizing their simplicity, portability, convenience and ease of use. We have chosen this focus due in part that State Medicaid and state and local welfare service providers are agencies who do not typically participate in electronic services networks. This is primarily because care for the poor and indigent is logistically and financially burdensome due to a lack of resources at administrative levels. Put another way, there is usually no shortage of volunteer physicians but there is a shortage of program administrators, clinics, medical supplies and patient access. Additionally, we believe that a company that enters this loop to complete the link by providing utility and value to participants will be embraced. It is incumbent on us to therefore extend our marketing strategy to facilitate this reality.
09/30/2010
Since inception, we have and will continue to focus our marketing efforts towards general medical and pharmaceutical medical applications through our E-Health and EMR smart cell phone information appliance ) software application package, and a permanently affixed handheld information appliance and commercial national cell phone network. Specifically we have marketed our line of MD@Hand smart cell phone-based medical communication network products to the medical insurance and pharmacy benefits management segments of the healthcare markets.
We have implemented a targeted marketing campaign to educate healthcare providers about our medical technology solutions; targeting the physician providers who specialize in care for the indigent through the provision of technology, products and services that specifically respond to the needs and requirements of that market. We market our suite of medical software products by emphasizing their simplicity, portability, convenience and ease of use. We have chosen this focus due in part that state Medicaid and state and local welfare service providers are agencies who do not typically participate in electronic services networks. This is primarily because care for the poor and indigent is logistically and financially burdensome due to a lack of resources at administrative levels. Put another way, there is usually no shortage of volunteer physicians but there is a shortage of program administrators, clinics, medical supplies and patient access. Additionally, we believe that a company that enters this loop to complete the link by providing utility and value to participants will be embraced. It is incumbent on us to therefore extend our marketing strategy to facilitate this reality.
ISCR's MD@hand Revenues = ????
Maybe it's time to measure the effectiveness of this targeted marketing campaign.
ALL IMHO
ID Super, I got a virus when I opened up the blondes
Lakes, I am not short ISCR. I have a fairly low cost basis and already have taken some profits as well. If the stock drops after the 3Q I may buy some more (depending on why it dropped). If the price rises I will take some off the table. My strategy with penny stocks is always to try to get on all house shares if any way possible. Not there yet, but working on it. I learned never to buy into all the hype. My strategy has back fired a few times when I might have sold a litlle too prematurely, but there is never anything wrong with taking a profit. I had bought Deidrich Coffee at .30 and sold pieces as the price was rising. Unfortunately I sold my last block around $ 15.00, the stock more than doubled from that point. Of course, I have stories of holding too long and losing, but I guess we all do.
I am interested in reading the upcoming quarterly report, I am not expecting anything earth shattering as far as the financials, and some may even be disappointed. But, I would'nt mind a pleasant surprise. ALL IMHO
Sensy, I have never accused the company of fraudulent behavior. So please stop with your false accusations. I do have some strong opinions of certain posters and their motives.
In the interest of maintaining integrity and decorum on this board, this is my last response to you.
Now run along!
sensy, super-now run along and find an audience that will listen to your senseless drivel. (oh almost forgot you state school grads say senseless dribble)
Sensy, I don't understand your message. I have positioned myself to take advantage of a movement in either direction. I am sure there will something good in 3Q. Maybe 9 companies will have approached ISCR about MD@hand. ALL IMHO
Hope you have a wonderful day!
Lakes, I agree with your post. I wonder what the effect of working to get Genstrips launched will have on the revenues and expenses for the 3rd quarter? I was thinking of adding some more shares last week but I decided to wait until after the Q comes out.
ID Super, I am not expecting much in the next 10 Q. I suspect that sales could be disappointing since I assume alot of energy and resources have been spent on GenStrips. Hope I'm wrong.
Lakes, don't mean to tarnish your reputation by being a supporter, but you hit the nail on the head. J & J's budget for employee toilet paper is more than ISCR's market cap(assuming they provide double ply).
Lakes, I am a supporter of the free exchange of ideas and thoughts. Often, we learn from those we disagree with, although I do struggle with finding something positive from Mr. Sensitivity. ( i guess that's my own character flaw).
Good luck with your investment, I would love to see .08 to .10 again.
Also, any thoughts on outstanding shares from the next quarterly report?
Any thoughts about a Johnson and Johnson response to Genstrips?
I wonder if all the personal attacks are a diversion to take attention away from what is not happening? It would be nice if all these so called insiders would stop spending 24/7 posting on message boards and get back to work. ALL IMHO
Here's one of my favorite shareholder entitlements:
The Right to Transfer Ownership
Right to transfer ownership means shareholders are allowed to trade their stock on an exchange. The right to transfer ownership might seem mundane, but the liquidity provided by stock exchanges is extremely important. Liquidity is one of the key factors that differentiates stocks from an investment like real estate. If you own property, it can take months to convert your investment into cash. Because stocks are so liquid, you can move your money into other places almost instantaneously.
So stop trying to trample on the rights of others! Flipping is a stock holders entitlement.
Lemons on sour dough bread.
So long as Lakes is happy when he buys or sells I am happy for him. It's his money, it's his business. I will probably sell some again at .08-.10 as well. Nothing wrong with a double! Have a great day!
Personally, I get tired of all the short talk. I think Lakes hit the nail on the head in that the real issue is a general lack of investor interest. It seems that investors do not have the confidence that ISCR can actually achieve their stated goals. Quite frankly, the past history of ISCR would support that conclusion. That doesn't mean they won't be successful this time, but I think investors are waiting on some more concrete evidence. All IMHO
I was searching on Instacare and found this site:
http://instacare.com/
VV, as you have mentioned before the company will provide info/updates whenever they choose. I think that includes both positive and negative news.
KS, the entire pr dated 6/24 was about GenStrips. My last post concerning this topic.